SEC Form 4 · accession 0001209191-17-021403
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Weishar
Officer — Chief Executive Officer · Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Mar 15, 2017 | M | 155,836 | $18.48 | A | 964,810 | D | |
| Common Stock, $0.01 par value | holding | — | — | — | 1,500 | I | By Son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.48 | Mar 15, 2017 | M | 155,836 | D | — | Mar 16, 2017 | Common Stock ($.01 par value ) | 155,836 | 0 | D |
Explanation of responses
- F1The options vested in the following amounts on the following dates: 38,959 options on 03/16/2011, 38,959 options on 03/16/2012, 38,959 options on 03/16/2013 and 38,959 options on 03/16/2014.